What is IntegriChain's business focus and history?
IntegriChain is a funded company based in Philadelphia, United States, founded in 2005 by Josh Halpern. It operates as a provider of revenue optimization technology and insights for the pharmaceutical industry. IntegriChain has raised a total of $2 million across 4 funding rounds from investors including Accel-KKR, SaaS Capital, and Activate Venture Partners. The company has 718 employees and offers products like the ICyte Platform, Net Revenue Suite, and Commercial Data Suite. Its top competitors include companies like Indegene, Axtria, and ACTO.
IntegriChain Corporate Details & Core Services
IntegriChain is the leading provider of revenue optimization technology and insights for the pharmaceutical industry. The company's ICyte data-driven commercialization platform enables manufacturers to develop, implement, and operate sustainable growth strategies for life-changing science. Through its unique focus on data, SaaS and BPaaS technology, consulting, and outsourcing, IntegriChain helps manufacturers connect the commercial, financial, and operational dimensions of drug access – all the way from demand through to net revenue optimization.
IntegriChain Contact Information & Official Links
What are IntegriChain's Key Business Metrics & Stats?
No of employees 718
Founded year 2005
Type private
SAICS CODE 5122
NAICS Code 5112
Industry Software Development
Location Philadelphia, Pennsylvania, United States
Subsidiary Company
bluefingroup.com, federalcompliance.com
Pricing Strategy Custom pricing based on solutions and services
IntegriChain
Firmographic Snapshot
2026
2005
Founded Year
718
Global Employees
United States
Headquarters
Software Development Industry
Private
Type
Verified by
DexterAgent.ai
How much funding has IntegriChain raised to date?
Name
Description
Funding Amount
USD 2 Million
Stage
Series B
Latest Valuation
(USD)
Lead Investor
Activate Venture Partners
Investors
Activate Venture Partners, Cross Atlantic Capital Partners
What are IntegriChain's Core Products?
Name
Description
ICyte Platform
A data-driven commercialization platform enabling pharmaceutical manufacturers to develop and operate sustainable growth strategies.
Net Revenue Suite
Solutions for government pricing, state price transparency reporting, claims data management, and distribution contracts.
Commercial Data Suite
Services including channel data aggregation, patient data aggregation, master data management, and analytics.
What are the latest developments at IntegriChain?
Date
Type
Description
August, 2025
Appointment
IntegriChain appoints Shai Fiss as Chief AI and Technology Officer to drive innovation and enhance customer experience.
October, 2025
Product Launch
IntegriChain launches AI-powered State Price Transparency Reporting system.
IntegriChain VS Indegene VS Axtria VS ACTO : 2026 Comparison
Feature
IntegriChain
Indegene
Axtria
ACTO
Core Strengths ICyte Platform, Net Revenue Suite, Commercial Data Suite
Cortex
Axtria DataMAxâ„¢, Axtria InsightsMAx.ai, Axtria SalesIQâ„¢, Axtria MarketingIQâ„¢, Axtria CustomerIQâ„¢
LAICA RepAssistâ„¢, CxZone
Founded Year 2005
1998
2010
Stock Name/Ticker INDGN (NSE), 544172 (BSE)
Type private
public
private
private
Global Employees 718
5081
4000
200
Revenue (Annual) $500 Million(2025)
$332.4 Million(2025)
Headquarters Philadelphia, Pennsylvania, United States
Bengaluru, Karnataka, India
Berkeley Heights, New Jersey, United States
Toronto, Ontario, Canada
Latest Valuation
$220 Million
$0
LATEST REVENUE (TRILLIONS USD)
EMPLOYEE COUNT (THOUSANDS)
INNOVATORS
VISIONARIES
DISRUPTORS
GIANTS
Indegene
332.4 | 5081
Competitive Landscape 2026
DexterAgent.ai
What are IntegriChain's official legal and registration details?
Name
Description
Legal Name
IntegriChain, Inc.
Cin number
GST number
Registration number
Who is in IntegriChain's executive leadership team?
Name
Designation
CEO
Josh Halpern
Chief Financial Officer
Matt Heyman
Chief Operating Officer
Sean Downey
Chief Commercial Officer
Tim Murdoch
Chief AI and Technology Officer
Shai Fiss
Where are IntegriChain's primary office locations?
City
Country
Philadelphia
United States
Ambler
United States
Pune
India
What are the current business signals and market intelligence for IntegriChain?
Spending next 3 months
AI integration, Product development, Customer experience enhancement
Pain points
Revenue leakage, Data quality issues, Compliance challenges
Sales motion
Direct sales, Consultative selling
Buyer Persona
Pharmaceutical executives, Market access professionals, Finance leaders
Type of customer
Pharmaceutical manufacturers
Key customer domain
What is IntegriChain's annual revenue history?
Year
Revenue (USD)
2025
500 Million
What are IntegriChain's risk management and compliance ratings?
GDPR RIsk
No
Privacy Risk
No
Company Ratings
Glassdoor Rating
Saas
Yes
Offline Stores
No
Service
Yes
Ecommerce
No
Exporter
No
Mobile App
No
Retail
No
B2B
Yes
B2C
No
Manufacturing
No
Wholesale
No
Importer
No
